Paul Karpecki

Advisory Board Member at OcuTerra Therapeutics

Dr. Karpecki received his doctor of optometry degree from Indiana University and completed a Durrie Fellowship in Medical Cornea/Refractive Surgery in Kansas City in affiliation with the Pennsylvania College of Optometry. He currently serves as Director of Cornea and External Disease for the Kentucky Eye Institute in Lexington KY. He is the Chief Clinical Editor for Review of Optometry, the most read journal in the profession and chairman of the New Technology and Treatment Conferences. He is Medical Director for KEPLR Vision and Director of Cornea and External Disease for the Center for Sight in Carmel IN. He was appointed to the Delphi International Society at Wilmer Johns Hopkins which included the top 25 dry eye experts in the world and co-chair for the previous two Tear Film and Ocular Surface Society Symposia. He served on the DEWS II Diagnostic Methodology Committee. In 2017-2018 he completed a full year preceptorship in advanced retinal disease at Retina Associates of Kentucky, one of the top 20 retina practices in the country. Dr. Karpecki is also an Associate Professor at the Kentucky College of Optometry in Pikeville KY and serves on the board of the charitable organization Optometry Giving Sight.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


OcuTerra Therapeutics

OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity


Industries

Employees

1-10

Links